S V Rana Selected Research

S V Rana Research Topics

Disease

6	Infections 10/2006 - 02/2001
4	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 10/2012 - 11/2004
4	Dyspepsia (Indigestion) 10/2006 - 10/2000
3	Inflammation (Inflammations) 10/2012 - 03/2006
3	Celiac Disease (Celiac Sprue) 06/2009 - 03/2007
3	Ulcer 03/2006 - 10/2000
3	Rotavirus Infections 01/2005 - 02/2001
2	Type 2 Diabetes Mellitus (MODY) 03/2017 - 07/2001
2	Lactose Intolerance (Intolerance, Lactose) 03/2017 - 03/2004
2	Meningeal Tuberculosis (Tuberculous Meningitis) 07/2010 - 06/2010
2	Duodenal Ulcer (Curling's Ulcer) 03/2006 - 07/2001
2	Giardiasis 02/2005 - 10/2000
1	COVID-19 01/2022
1	Pancreatitis 01/2019
1	Hyperglycemia 03/2017
1	Ulcerative Colitis 04/2014
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Renal Insufficiency (Renal Failure) 07/2012
1	Chronic Disease (Chronic Diseases) 07/2012
1	Chronic Renal Insufficiency 07/2012
1	Neoplasms (Cancer) 06/2011
1	Atherosclerosis 06/2011
1	Necrosis 10/2010
1	HIV Infections (HIV Infection) 12/2009
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 07/2008
1	Hypothyroidism 07/2008
1	Pathologic Constriction (Stenosis) 07/2008
1	Peptic Ulcer (Peptic Ulcers) 07/2008
1	Systemic Scleroderma (Systemic Sclerosis) 07/2008
1	Tuberculosis (Tuberculoses) 03/2008
1	Body Weight (Weight, Body) 03/2008
1	Wounds and Injuries (Trauma) 10/2006
1	Diarrhea 01/2005
1	Urogenital Diseases 12/2001
1	Infertility (Sterility) 12/2001
1	Opportunistic Infections (Opportunistic Infection) 12/2001
1	Muscle Spasticity (Spastic) 10/2001

Drug/Important Bio-Agent (IBA)

8	HydrogenIBA 03/2017 - 10/2001
5	AntioxidantsIBA 04/2014 - 07/2001
4	Lactose FDA LinkGeneric 03/2017 - 03/2004
3	Glutathione (Reduced Glutathione)IBA 12/2009 - 01/2001
3	EnzymesIBA 03/2008 - 10/2000
3	LactaseIBA 03/2006 - 10/2000
3	Amino Acids FDA Link 01/2005 - 02/2001
3	Trypsin InhibitorsIBA 01/2005 - 02/2001
3	DisaccharidasesIBA 07/2001 - 10/2000
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2000
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2012
2	Xylose (D-Xylose)FDA Link 03/2017 - 03/2007
2	CatalaseIBA 04/2014 - 10/2006
2	Adenosine DeaminaseIBA 07/2010 - 06/2010
2	LipidsIBA 03/2008 - 01/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2006 - 12/2001
2	Leucine (L-Leucine)FDA Link 03/2006 - 02/2001
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2006 - 01/2001
2	alpha-Glucosidases (Acid Maltase)IBA 03/2006 - 10/2000
2	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 03/2006 - 10/2000
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2003 - 12/2001
1	VaccinesIBA 01/2022
1	SolutionsIBA 01/2022
1	Insulin (Novolin)FDA Link 03/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2013
1	CytokinesIBA 10/2012
1	MicronutrientsIBA 07/2012
1	CreatinineIBA 07/2012
1	Lactulose (Duphalac)FDA LinkGeneric 01/2012
1	SulfurIBA 06/2011
1	Lipoproteins (Lipoprotein)IBA 06/2011
1	oxidized low density lipoproteinIBA 06/2011
1	allicinIBA 06/2011
1	Carotenoids (Carotene)IBA 10/2010
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	CausticsIBA 07/2008
1	CholesterolIBA 03/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2008
1	Triglycerides (Triacylglycerol)IBA 03/2008
1	Isoniazid (Ftivazide)FDA LinkGeneric 03/2008
1	TransglutaminasesIBA 10/2007
1	Immunoglobulin A (IgA)IBA 10/2007
1	Superoxide DismutaseIBA 10/2006
1	Peptide Hydrolases (Proteases)FDA Link 03/2006
1	Dietary Fiber FDA Link 11/2004
1	Oxidants (Oxidizing Agents)IBA 12/2003
1	NitrogenIBA 12/2003
1	NitritesIBA 12/2003
1	IsoprostanesIBA 12/2003
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2001
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 12/2001
1	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2001
1	Reactive Nitrogen SpeciesIBA 12/2001
1	Arginine (L-Arginine)FDA Link 12/2001
1	Free RadicalsIBA 12/2001
1	Oxygen (Dioxygen)IBA 12/2001
1	Oxidoreductases (Dehydrogenase)IBA 12/2001
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2001
1	TrypsinIBA 10/2001

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2009
1	Vagotomy 07/2008
1	Oral Administration 03/2008
1	Chemoprevention 03/2008